Dr. Rahul Dilip Tendulkar, MD

Dr. Tendulkar practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Dr. Tendulkar's NPI, 1558546432, was assigned on January 9, 2008. Dr. Tendulkar graduated from University of Michigan Medical School in 2003. Dr. Tendulkar holds Ohio license 35.091189.

Dr. Tendulkar's primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

Dr. Tendulkar's primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. Dr. Tendulkar is also affiliated with Cleveland Clinic Akron General. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Tendulkar to 3 more hospitals, 2 clinical labs and 1 medical group, each named with a free account. Dr. Tendulkar's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tendulkar practices, 7 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Tendulkar's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Tendulkar is licensed in Ohio.

CMS data shows 1,544 Medicare services from Dr. Tendulkar across 18 procedure codes in 2024, for 349 Medicare patients. Medicare paid $129,921 for them.

CMS counts 349 Medicare patients who saw Dr. Tendulkar in 2024. The largest group is 65 to 74, with 214 patients. 75% of them have cancer, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Tendulkar's median patient age at 67, with 36% women.

In 2024, Dr. Tendulkar wrote 124 Medicare Part D claims for 51 patients. 100% of them were for generic drugs. CMS names the drug for 88 of them, across 1 drug with 11 or more claims each, at $791 in total drug cost. In 2023, CMS named 118 claims across 2 drugs.

Dr. Tendulkar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tendulkar as offering telehealth.

Dmand AI links 99 papers to Dr. Tendulkar, published from 2007 to 2025. 2016 was the busiest year, with 10. The most frequent topics are Breast Neoplasms, Prostatic Neoplasms and Mastectomy, Segmental. Dr. Tendulkar has published most often in Int J Radiat Oncol Biol Phys. Dr. Tendulkar's most frequent co-authors are Kevin Lee Stephans, MD, Chirag Sudhir Shah, MD and Sheen Cherian, MD.

Dmand AI links Dr. Tendulkar to 4 clinical trials. 4 are still active or recruiting. Conditions studied include Prostatic Neoplasms, Prostatic Diseases and Breast Neoplasms.

CMS Open Payments shows 33 general payments to Dr. Tendulkar from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 89% of the total. Varian Medical Systems, Inc. paid the most, $23,969.

Dr. Tendulkar graduated from University of Michigan Medical School in 2003.